High glucose reduces Nrf2-dependent cRAGE release and enhances inflammasome-dependent IL-1β production in monocytes: the modulatory effects of EGCG

Soluble receptor for advanced glycation end products (sRAGE) acts as a decoy sequestering of RAGE ligands, thus preventing the activation of the ligand-RAGE axis linking human diseases. However, the molecular mechanisms underlying sRAGE remain unclear. In this study, THP-1 monocytes were cultured in...

Full description

Saved in:
Bibliographic Details
Main Authors: Chi-Hao Wu, Yin-Hsuan Chang, Chin-Lin Hsu, Sheng-Yi Chen, Gow-Chin Yen
Format: Article
Language:English
Published: Tsinghua University Press 2024-05-01
Series:Food Science and Human Wellness
Subjects:
Online Access:https://www.sciopen.com/article/10.26599/FSHW.2022.9250129
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841550225732272128
author Chi-Hao Wu
Yin-Hsuan Chang
Chin-Lin Hsu
Sheng-Yi Chen
Gow-Chin Yen
author_facet Chi-Hao Wu
Yin-Hsuan Chang
Chin-Lin Hsu
Sheng-Yi Chen
Gow-Chin Yen
author_sort Chi-Hao Wu
collection DOAJ
description Soluble receptor for advanced glycation end products (sRAGE) acts as a decoy sequestering of RAGE ligands, thus preventing the activation of the ligand-RAGE axis linking human diseases. However, the molecular mechanisms underlying sRAGE remain unclear. In this study, THP-1 monocytes were cultured in normal glucose (NG, 5.5 mmol/L) and high glucose (HG, 15 mmol/L) to investigate the effects of diabetesrelevant glucose concentrations on sRAGE and interleukin-1β (IL-1β) secretion. The modulatory effects of epigallocatechin gallate (EGCG) in response to HG challenge were also evaluated. HG enhanced intracellular reactive oxygen species (ROS) generation and RAGE expression. The secretion of sRAGE, including esRAGE and cRAGE, was reduced under HG conditions, together with the downregulation of a disintegrin and metallopeptidase 10 (ADAM10) and nuclear factor erythroid 2-related factor 2 (Nrf2) nuclear translocation. Mechanistically, the HG effects were counteracted by siRAGE and exacerbated by siNrf2. Chromatin immunoprecipitation results showed that Nrf2 binding to the ADAM10 promoter and HG interfered with this binding. Our data reinforce the notion that RAGE and Nrf2 might be sRAGE-regulating factors. Un der HG conditions, the treatment of EGCG reduced ROS generation and RAGE activation. EGCG-stimulated cRAGE release was likely caused by the upregulation of the Nrf2-ADAM10 pathway. EGCG inhibited HG-mediated NLRP3 inf lammasome activation at least partly by stimulating sRAGE, thereby reducing IL-1β release.
format Article
id doaj-art-f10c05030e8a4268bdd12e535237aa7b
institution Kabale University
issn 2097-0765
2213-4530
language English
publishDate 2024-05-01
publisher Tsinghua University Press
record_format Article
series Food Science and Human Wellness
spelling doaj-art-f10c05030e8a4268bdd12e535237aa7b2025-01-10T06:54:23ZengTsinghua University PressFood Science and Human Wellness2097-07652213-45302024-05-011331531154210.26599/FSHW.2022.9250129High glucose reduces Nrf2-dependent cRAGE release and enhances inflammasome-dependent IL-1β production in monocytes: the modulatory effects of EGCGChi-Hao Wu0Yin-Hsuan Chang1Chin-Lin Hsu2Sheng-Yi Chen3Gow-Chin Yen4Graduate Programs of Nutrition Science, School of Life Science, Taiwan Normal University, Taipei 106209, Taiwan, ChinaDepartment of Food Science and Biotechnology, Chung Hsing University, Taichung 40227, Taiwan, ChinaSchool of Nutrition, Chung Shan Medical University, Taichung 40201, Taiwan, ChinaDepartment of Food Science and Biotechnology, Chung Hsing University, Taichung 40227, Taiwan, ChinaDepartment of Food Science and Biotechnology, Chung Hsing University, Taichung 40227, Taiwan, ChinaSoluble receptor for advanced glycation end products (sRAGE) acts as a decoy sequestering of RAGE ligands, thus preventing the activation of the ligand-RAGE axis linking human diseases. However, the molecular mechanisms underlying sRAGE remain unclear. In this study, THP-1 monocytes were cultured in normal glucose (NG, 5.5 mmol/L) and high glucose (HG, 15 mmol/L) to investigate the effects of diabetesrelevant glucose concentrations on sRAGE and interleukin-1β (IL-1β) secretion. The modulatory effects of epigallocatechin gallate (EGCG) in response to HG challenge were also evaluated. HG enhanced intracellular reactive oxygen species (ROS) generation and RAGE expression. The secretion of sRAGE, including esRAGE and cRAGE, was reduced under HG conditions, together with the downregulation of a disintegrin and metallopeptidase 10 (ADAM10) and nuclear factor erythroid 2-related factor 2 (Nrf2) nuclear translocation. Mechanistically, the HG effects were counteracted by siRAGE and exacerbated by siNrf2. Chromatin immunoprecipitation results showed that Nrf2 binding to the ADAM10 promoter and HG interfered with this binding. Our data reinforce the notion that RAGE and Nrf2 might be sRAGE-regulating factors. Un der HG conditions, the treatment of EGCG reduced ROS generation and RAGE activation. EGCG-stimulated cRAGE release was likely caused by the upregulation of the Nrf2-ADAM10 pathway. EGCG inhibited HG-mediated NLRP3 inf lammasome activation at least partly by stimulating sRAGE, thereby reducing IL-1β release.https://www.sciopen.com/article/10.26599/FSHW.2022.9250129epigallocatechin gallate (egcg)inflammasomenuclear factor erythroid 2-related factor 2 (nrf2)receptor for advanced glycation end products (rage)soluble rage (srage)
spellingShingle Chi-Hao Wu
Yin-Hsuan Chang
Chin-Lin Hsu
Sheng-Yi Chen
Gow-Chin Yen
High glucose reduces Nrf2-dependent cRAGE release and enhances inflammasome-dependent IL-1β production in monocytes: the modulatory effects of EGCG
Food Science and Human Wellness
epigallocatechin gallate (egcg)
inflammasome
nuclear factor erythroid 2-related factor 2 (nrf2)
receptor for advanced glycation end products (rage)
soluble rage (srage)
title High glucose reduces Nrf2-dependent cRAGE release and enhances inflammasome-dependent IL-1β production in monocytes: the modulatory effects of EGCG
title_full High glucose reduces Nrf2-dependent cRAGE release and enhances inflammasome-dependent IL-1β production in monocytes: the modulatory effects of EGCG
title_fullStr High glucose reduces Nrf2-dependent cRAGE release and enhances inflammasome-dependent IL-1β production in monocytes: the modulatory effects of EGCG
title_full_unstemmed High glucose reduces Nrf2-dependent cRAGE release and enhances inflammasome-dependent IL-1β production in monocytes: the modulatory effects of EGCG
title_short High glucose reduces Nrf2-dependent cRAGE release and enhances inflammasome-dependent IL-1β production in monocytes: the modulatory effects of EGCG
title_sort high glucose reduces nrf2 dependent crage release and enhances inflammasome dependent il 1β production in monocytes the modulatory effects of egcg
topic epigallocatechin gallate (egcg)
inflammasome
nuclear factor erythroid 2-related factor 2 (nrf2)
receptor for advanced glycation end products (rage)
soluble rage (srage)
url https://www.sciopen.com/article/10.26599/FSHW.2022.9250129
work_keys_str_mv AT chihaowu highglucosereducesnrf2dependentcragereleaseandenhancesinflammasomedependentil1bproductioninmonocytesthemodulatoryeffectsofegcg
AT yinhsuanchang highglucosereducesnrf2dependentcragereleaseandenhancesinflammasomedependentil1bproductioninmonocytesthemodulatoryeffectsofegcg
AT chinlinhsu highglucosereducesnrf2dependentcragereleaseandenhancesinflammasomedependentil1bproductioninmonocytesthemodulatoryeffectsofegcg
AT shengyichen highglucosereducesnrf2dependentcragereleaseandenhancesinflammasomedependentil1bproductioninmonocytesthemodulatoryeffectsofegcg
AT gowchinyen highglucosereducesnrf2dependentcragereleaseandenhancesinflammasomedependentil1bproductioninmonocytesthemodulatoryeffectsofegcg